CONTACT US

Monteagudo E, Fonsi M, Chu X, Bleasby K, Evers R, Pucci V, Orsale MV, Cianetti S, Ferrara M, Harper S, Laufer R, Rowley M, Summa V. (2010) The metabolism and disposition of a potent inhibitor of hepatitis C virus NS3/4A protease. Xenobiotica. 2010 Dec;40(12):826-39.

Ferrara M, Fiore F, Summa V, Gardelli C. (2010) Development of 2-pyrrolidinyl-N-methyl pyrimidones as potent and orally bioavailable HIV integrase inhibitors. Bioorg Med Chem Lett. 2010 Sep 1;20(17):5031-4.

Peruzzi D, Gavazza A, Mesiti G, Lubas G, Scarselli E, Conforti A, Bendtsen C, Ciliberto G, La Monica N, Aurisicchio L. (2010) A vaccine targeting telomerase enhances survival of dogs affected by B-cell lymphoma. Mol Ther. 2010 Aug;18(8):1559-67.

Cipriani B. (2009) Immunological markers of cancer vaccine efficacy and their clinical relevance. Biomark Med. 2009 Jun;3(3):253-64.

Malancona S, Donghi M, Ferrara M, Martin Hernando JI, Pompei M, Pesci S, Ontoria JM, Koch U, Rowley M, Summa V. (2010) Allosteric inhibitors of hepatitis C virus NS5B polymerase thumb domain site II: structure-based design and synthesis of new templates. Bioorg Med Chem. 2010 Apr 15;18(8):2836-48.

Cianetti S, Cooper VB, Attenni B, Pucci V, Fiore F, Giuliano C, Laufer R, Gardelli C, Monteagudo E, Narjes F, Pearce GE, Rowley M. (2010) Enhancement of intestinal absorption of 2-methyl cytidine prodrugs. Drug Deliv. 2010 May;17(4):214-22.

Pescatore G, Branca D, Fiore F, Kinzel O, Bufi LL, Muraglia E, Orvieto F, Rowley M, Toniatti C, Torrisi C, Jones P. (2010) Identification and SAR of novel pyrrolo[1,2-a]pyrazin-1(2H)-one derivatives as inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1). Bioorg Med Chem Lett. 2010 Feb 1;20(3):1094-9.

Ferrigno F, Branca D, Kinzel O, Lillini S, Llauger Bufi L, Monteagudo E, Muraglia E, Rowley M, Schultz-Fademrecht C, Toniatti C, Torrisi C, Jones P. (2010) Development of substituted 6-[4-fluoro-3-(piperazin-1-ylcarbonyl)benzyl]-4,5-dimethylpyridazin-3(2H)-ones as potent poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors active in BRCA deficient cells. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1100-5.

Torrisi C, Bisbocci M, Ingenito R, Ontoria JM, Rowley M, Schultz-Fademrecht C, Toniatti C, Jones P. (2010) Discovery and SAR of novel, potent and selective hexahydrobenzonaphthyridinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1). Bioorg Med Chem Lett. 2010 Jan 15;20(2):448-52.

Scarpelli R, Boueres JK, Cerretani M, Ferrigno F, Ontoria JM, Rowley M, Schultz-Fademrecht C, Toniatti C, Jones P. (2010) Synthesis and biological evaluation of substituted 2-phenyl-2H-indazole-7-carboxamides as potent poly(ADP-ribose) polymerase (PARP) inhibitors. Bioorg Med Chem Lett. 2010 Jan 15;20(2):488-92.

Peruzzi D, Mesiti G, Ciliberto G, La Monica N, Aurisicchio L. (2010) Telomerase and HER-2/neu as targets of genetic cancer vaccines in dogs. Vaccine. 2010 Feb 3;28(5):1201-8.

Pompei M, Di Francesco ME, Pesci S, Koch U, Vignetti SE, Veneziano M, Pace P, Summa V. (2010) Novel P2-P4 macrocyclic inhibitors of HCV NS3/4A protease by P3 succinamide fragment depeptidization strategy. Bioorg Med Chem Lett. 2010 Jan 1;20(1):168-74.

Ingenito R, Burton C, Langella A, Chen X, Zytko K, Pessi A, Wang J, Bianchi E. (2010) Novel potent apoA-I peptide mimetics that stimulate cholesterol efflux and pre-beta particle formation in vitro. Bioorg Med Chem Lett. 2010 Jan 1;20(1):236-9.

Verdirame M, Veneziano M, Alfieri A, Di Marco A, Monteagudo E, Bonelli F. (2010) Turbulent flow chromatography TFC-tandem mass spectrometry supporting in vitro/vivo studies of NCEs in high throughput fashion. J Pharm Biomed Anal. 2010 Mar 11;51(4):834-41.